| Encompass Home Health & Hospice Of Idaho 16151 N Brinson Street, Nampa, ID, 83687 | |
| (208) 461-1600 |
News Archive
Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Telemedicine, which allows doctors to communicate, diagnose and even treat their patients remotely is on the rise thanks to advances in information technology. It allows healthcare workers to securely monitor patients in inaccessible parts of the world as well as providing more timely responses for patients in many situations.
Dr. John D. Statler, a board-certified, fellowship-trained Interventional Radiologist with Virginia Interventional & Vascular Associates, is one of only 23 physicians nationwide selected this year as new Fellows in the Society of Interventional Radiology.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
› Verified 2 days ago
| Name | Encompass Home Health & Hospice Of Idaho |
|---|---|
| Location | 16151 N Brinson Street, Nampa, Idaho |
| Hospice ID | 131540 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 130 |
News Archive
Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Telemedicine, which allows doctors to communicate, diagnose and even treat their patients remotely is on the rise thanks to advances in information technology. It allows healthcare workers to securely monitor patients in inaccessible parts of the world as well as providing more timely responses for patients in many situations.
Dr. John D. Statler, a board-certified, fellowship-trained Interventional Radiologist with Virginia Interventional & Vascular Associates, is one of only 23 physicians nationwide selected this year as new Fellows in the Society of Interventional Radiology.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
› Verified 2 days ago
| NPI Number | 1154470490 |
| Organization Name | Guardian Home Care, Inc |
| Address | 16151 N Brinson St Nampa, Idaho, 83687 |
| Phone Number | (208)461-1600 |
News Archive
Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Telemedicine, which allows doctors to communicate, diagnose and even treat their patients remotely is on the rise thanks to advances in information technology. It allows healthcare workers to securely monitor patients in inaccessible parts of the world as well as providing more timely responses for patients in many situations.
Dr. John D. Statler, a board-certified, fellowship-trained Interventional Radiologist with Virginia Interventional & Vascular Associates, is one of only 23 physicians nationwide selected this year as new Fellows in the Society of Interventional Radiology.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 94.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 93.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.9 | 97.3 |
| Patients who got timely treatment for shortness of breath | 92.2 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 90.1 | 93.3 |
News Archive
Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Telemedicine, which allows doctors to communicate, diagnose and even treat their patients remotely is on the rise thanks to advances in information technology. It allows healthcare workers to securely monitor patients in inaccessible parts of the world as well as providing more timely responses for patients in many situations.
Dr. John D. Statler, a board-certified, fellowship-trained Interventional Radiologist with Virginia Interventional & Vascular Associates, is one of only 23 physicians nationwide selected this year as new Fellows in the Society of Interventional Radiology.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
› Verified 2 days ago
| Home Health Aides | 6 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 3 |
| Medical Social Workers | 7 |
| Physicians | 5 |
| Registered Nurses | 11 |
| Other Personnel | 5.5 |
| Total Employees | 38.5 |
|---|
News Archive
Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.
Telemedicine, which allows doctors to communicate, diagnose and even treat their patients remotely is on the rise thanks to advances in information technology. It allows healthcare workers to securely monitor patients in inaccessible parts of the world as well as providing more timely responses for patients in many situations.
Dr. John D. Statler, a board-certified, fellowship-trained Interventional Radiologist with Virginia Interventional & Vascular Associates, is one of only 23 physicians nationwide selected this year as new Fellows in the Society of Interventional Radiology.
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
› Verified 2 days ago
| Encompass Home Health & Hospice Of Idaho Location: 16151 N Brinson Street, Nampa, Idaho, 83687 Phone: (208) 461-1600 |
| Journeys Hospice Location: 223 East Amity, Nampa, Idaho, 83686 Phone: (208) 461-1600 |
| Treasure Valley Hospice Location: 8 6th Street North, Suite 200, Nampa, Idaho, 83687 Phone: (208) 461-1600 |